Galecto Announces Reverse Stock Split: A Game-Changing Move for the Company
Galecto, Inc. Announces 1-for-25 Reverse Stock Split Breaking News: Galecto, Inc. Takes Action to Maintain Nasdaq Listing BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company specializing in the development of innovative treatments for cancer and fibrosis, made a significant announcement today regarding the implementation of a 1-for-25 Reverse Stock…